• 1
    Lichtenstein L, Jaffe HL 1942 Fibrous dysplasia of bone: A condition affecting one, several or many bones, graver cases of which may present abnormal pigmentation of skin, premature sexual development, hyperthyroidism or still other extraskeletal abnormalities. Arch Path 33:777816.
  • 2
    Riminucci M, Fisher LW, Shenker A, Spiegel AM, Bianco P, Gehron Robey P 1997 Fibrous dysplasia of bone in the McCune-Albright syndrome: Abnormalities in bone formation. Am J Pathol 151:15871600.
  • 3
    Dorfman HD, Czerniak B 1998 Fibroosseous lesions. In: DorfmanHD, CzerniakB (eds.) Bone Tumors. Mosby, St. Louis, MO, USA, pp. 441491.
  • 4
    Riminucci M, Liu B, Corsi A, Shenker A, Spiegel AM, Robey PG, Bianco P 1999 The histopathology of fibrous dysplasia of bone in patients with activating mutations of the Gs alpha gene: Site-specific patterns and recurrent histological hallmarks. J Pathol 187:249258.
  • 5
    McCune DJ 1936 Osteitis fibrosa cystica: The case of a nine-year-old girl who also exhibits precocious puberty, multiple pigmentation of the skin and hyperthyroidism. Am J Dis Child 52:743744.
  • 6
    Albright F, Butler AM, Hampton AO, Smith P 1937 Syndrome characterized by osteitis fibrosa disseminata, areas, of pigmentation, and endocrine dysfunction, with precocious puberty in females: Report of 5 cases. N Engl J Med 216:727746.
  • 7
    Lee PA, Van Dop C, Migeon CJ 1986 McCune-Albright syndrome. Long-term follow-up. JAMA 256:29802984.
  • 8
    Collins MT, Chebli C, Jones J, Kushner H, Consugar M, Rinaldo P, Wientroub S, Bianco P, Robey PG 2001 Renal phosphate wasting in fibrous dysplasia of bone is part of a generalized renal tubular dysfunction similar to that seen in tumor-induced osteomalacia. J Bone Miner Res 16:806813.
  • 9
    Danon M, Crawford JD 1987 The McCune-Albright syndrome. Ergeb Inn Med Kinderheilkd 55:81115.
  • 10
    Akintoye SO, Chebli C, Booher S, Feuillan P, Kushner H, Leroith D, Cherman N, Bianco P, Wientroub S, Robey PG, Collins MT 2002 Characterization of gsp-mediated growth hormone excess in the context of McCune-Albright syndrome. J Clin Endocrinol Metab 87:51045112.
  • 11
    Lee JS, FitzGibbon E, Butman JA, Dufresne CR, Kushner H, Wientroub S, Robey PG, Collins MT 2002 Normal vision despite narrowing of the optic canal in fibrous dysplasia. N Engl J Med 347:16701676.
  • 12
    Corsi A, Collins MT, Riminucci M, Howell PG, Boyde A, Robey PG, Bianco P 2003 Osteomalacic and hyperparathyroid changes in fibrous dysplasia of bone: Core biopsy studies and clinical correlations. J Bone Miner Res 18:12351246.
  • 13
    Chebli C, Murphey MD, Wientroub S, Collins MT 2002 Orthopedic concerns in children with endocrine disorders. J Pediatr Orthop B 11:183191.
  • 14
    Greenspan SL, Greenspan FS 1999 The effect of thyroid hormone on skeletal integrity. Ann Intern Med 130:750758.
  • 15
    Weinstein LS, Shenker A, Gejman PV, Merino MJ, Friedman E, Spiegel AM 1991 Activating mutations of the stimulatory G protein in the McCune-Albright syndrome. N Engl J Med 325:16881695.
  • 16
    Schwindinger WF, Francomano CA, Levine MA 1992 Identification of a mutation in the gene encoding the alpha subunit of the stimulatory G protein of adenylyl cyclase in McCune-Albright syndrome. Proc Natl Acad Sci USA 89:51525156.
  • 17
    Bianco P, Kuznetsov SA, Riminucci M, Fisher LW, Spiegel AM, Robey PG 1998 Reproduction of human fibrous dysplasia of bone in immunocompromised mice by transplanted mosaics of normal and Gsalpha-mutated skeletal progenitor cells. J Clin Invest 101:17371744.
  • 18
    Harris WH, Dudley HR, Barry RJ 1962 The natural history of fibrous dysplasia. An orthopedic, pathological, and roentgenographic study. J Bone Joint Surg Am 44:207233.
  • 19
    Grabias SL, Campbell CJ 1977 Fibrous dysplasia. Orthop Clin North Am 8:771783.
  • 20
    Enneking WF, Gearen PF 1986 Fibrous dysplasia of the femoral neck. Treatment by cortical bone-grafting. J Bone Joint Surg Am 68:14151422.
  • 21
    Guille JT, Kumar SJ, MacEwen GD 1998 Fibrous dysplasia of the proximal part of the femur. Long-term results of curettage and bone-grafting and mechanical realignment. J Bone Joint Surg Am 80:648658.
  • 22
    Ippolito E, Bray EW, Corsi A, De Maio F, Exner UG, Robey PG, Grill F, Lala R, Massobrio M, Pinggera O, Riminucci M, Snela S, Zambakidis C, Bianco P 2003 Natural history and treatment of fibrous dysplasia of bone: A multicenter clinicopathologic study promoted by the European Pediatric Orthopaedic Society. J Pediatr Orthop B 12:155177.
  • 23
    Lichtenstein L JH 1942 Fibrous dysplasia of bone: A condition affecting one, several or many bones, graver cases of which may present abnormal pigmentation of skin, premature sexual development, hyperthyroidism or still other extraskeletal abnormalities. Arch Path 33:777816.
  • 24
    Reed RJ 1963 Fibrous dysplasia of bone. A review of 25 cases. Arch Pathol 75:480495.
  • 25
    Kaplan FS, Fallon MD, Boden SD, Schmidt R, Senior M, Haddad JG 1988 Estrogen receptors in bone in a patient with polyostotic fibrous dysplasia (McCune-Albright syndrome). N Engl J Med 319:421425.
  • 26
    Mastorakos G, Mitsiades NS, Doufas AG, Koutras DA 1997 Hyperthyroidism in McCune-Albright syndrome with a review of thyroid abnormalities sixty years after the first report. Thyroid 7:433439.
  • 27
    Payne RB 1998 Renal tubular reabsorption of phosphate (TmP/GFR): Indications and interpretation. Ann Clin Biochem 35:201206.
  • 28
    O'Sullivan ME, Chao EY, Kelly PJ 1989 The effects of fixation on fracture-healing. J Bone Joint Surg Am 71:306310.
  • 29
    Paterson CR, McAllion S, Stellman JL 1984 Osteogenesis imperfecta after the menopause. N Engl J Med 310:16941696.
  • 30
    Happle R 1986 The McCune-Albright syndrome: A lethal gene surviving by mosaicism. Clin Genet 29:321324.
  • 31
    Riminucci M, Collins MT, Fedarko NS, Cherman N, Corsi A, White KE, Waguespack S, Gupta A, Hannon T, Econs MJ, Bianco P, Robey PG 2003 FGF-23 in fibrous dysplasia of bone and its relationship to renal phosphate wasting. J Clin Invest 112:683692.
  • 32
    Bianco P, Riminucci M, Majolagbe A, Kuznetsov SA, Collins MT, Mankani MH, Corsi A, Bone HG, Wientroub S, Spiegel AM, Fisher LW, Robey PG 2000 Mutations of the GNAS1 gene, stromal cell dysfunction, and osteomalacic changes in non-McCune-Albright fibrous dysplasia of bone. J Bone Miner Res 15:120128.
  • 33
    Terpstra L, Rauch F, Plotkin H, Travers R, Glorieux FH 2002 Bone mineralization in polyostotic fibrous dysplasia: Histomorphometric analysis. J Bone Miner Res 17:19491953.
  • 34
    Whyte M 1996 Hypophosphatemic bone disease in McCune-Albright syndrome. Calcif Tissue Int 59:224.
  • 35
    Stephenson RB, London MD, Hankin FM, Kaufer H 1987 Fibrous dysplasia. An analysis of options for treatment. J Bone Joint Surg Am 69:400409.
  • 36
    Kumta SM, Leung PC, Griffith JF, Kew J, Chow LT 2000 Vascularised bone grafting for fibrous dysplasia of the upper limb. J Bone Joint Surg Br 82:409412.
  • 37
    Keijser LC, Van Tienen TG, Schreuder HW, Lemmens JA, Pruszczynski M, Veth RP 2001 Fibrous dysplasia of bone: Management and outcome of 20 cases. J Surg Oncol 76:157168.
  • 38
    Bell NH, Avery S, Johnston CC Jr 1970 Effects of calcitonin in Paget's disease and polyostotic fibrous dysplasia. J Clin Endocrinol Metab 31:283290.
  • 39
    Long A, Loughlin T, Towers RP, McKenna TJ 1988 Polyostotic fibrous dysplasia with contrasting responses to calcitonin and mithramycin: Aetiological and therapeutic implications. Ir J Med Sci 157:229234.
  • 40
    Ruggieri P, Sim FH, Bond JR, Unni KK 1994 Malignancies in fibrous dysplasia. Cancer 73:14111424.
  • 41
    Liens D, Delmas PD, Meunier PJ 1994 Long-term effects of intravenous pamidronate in fibrous dysplasia of bone. Lancet 343:953954.
  • 42
    Chapurlat RD, Delmas PD, Liens D, Meunier PJ 1997 Long-term effects of intravenous pamidronate in fibrous dysplasia of bone. J Bone Miner Res 12:17461752.
  • 43
    Lala R, Matarazzo P, Bertelloni S, Buzi F, Rigon F, de Sanctis C 2000 Pamidronate treatment of bone fibrous dysplasia in nine children with McCune-Albright syndrome. Acta Paediatr 89:188193.
  • 44
    Lane JM, Khan SN, O'Connor WJ, Nydick M, Hommen JP, Schneider R, Tomin E, Brand J, Curtin J 2001 Bisphosphonate therapy in fibrous dysplasia. Clin Orthop 382:612.
  • 45
    O'Sullivan M, Zacharin M 2002 Intramedullary rodding and bisphosphonate treatment of polyostotic fibrous dysplasia associated with the McCune-Albright syndrome. J Pediatr Orthop 22:255260.